Literature DB >> 20852024

The use of SSMD-based false discovery and false nondiscovery rates in genome-scale RNAi screens.

Xiaohua Douglas Zhang1, Raul Lacson, Ruojing Yang, Shane D Marine, Alex McCampbell, Dawn M Toolan, Tim R Hare, Joleen Kajdas, Joel P Berger, Daniel J Holder, Joseph F Heyse, Marc Ferrer.   

Abstract

In genome-scale RNA interference (RNAi) screens, it is critical to control false positives and false negatives statistically. Traditional statistical methods for controlling false discovery and false nondiscovery rates are inappropriate for hit selection in RNAi screens because the major goal in RNAi screens is to control both the proportion of short interfering RNAs (siRNAs) with a small effect among selected hits and the proportion of siRNAs with a large effect among declared nonhits. An effective method based on strictly standardized mean difference (SSMD) has been proposed for statistically controlling false discovery rate (FDR) and false nondiscovery rate (FNDR) appropriate for RNAi screens. In this article, the authors explore the utility of the SSMD-based method for hit selection in RNAi screens. As demonstrated in 2 genome-scale RNAi screens, the SSMD-based method addresses the unmet need of controlling for the proportion of siRNAs with a small effect among selected hits, as well as controlling for the proportion of siRNAs with a large effect among declared nonhits. Furthermore, the SSMD-based method results in reasonably low FDR and FNDR for selecting inhibition or activation hits. This method works effectively and should have a broad utility for hit selection in RNAi screens with replicates.

Mesh:

Substances:

Year:  2010        PMID: 20852024     DOI: 10.1177/1087057110381919

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  12 in total

Review 1.  RNAi screening: new approaches, understandings, and organisms.

Authors:  Stephanie E Mohr; Norbert Perrimon
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-09-22       Impact factor: 9.957

2.  Automated selection of regions of interest for intensity-based FRET analysis of transferrin endocytic trafficking in normal vs. cancer cells.

Authors:  Ronak Talati; Andrew Vanderpoel; Amina Eladdadi; Kate Anderson; Ken Abe; Margarida Barroso
Journal:  Methods       Date:  2013-08-28       Impact factor: 3.608

Review 3.  High-throughput RNA interference screens integrative analysis: Towards a comprehensive understanding of the virus-host interplay.

Authors:  Sandeep Amberkar; Narsis A Kiani; Ralf Bartenschlager; Gualtiero Alvisi; Lars Kaderali
Journal:  World J Virol       Date:  2013-05-12

4.  cSSMD: assessing collective activity for addressing off-target effects in genome-scale RNA interference screens.

Authors:  Xiaohua Douglas Zhang; Francesca Santini; Raul Lacson; Shane D Marine; Qian Wu; Luca Benetti; Ruojing Yang; Alex McCampbell; Joel P Berger; Dawn M Toolan; Erica M Stec; Daniel J Holder; Keith A Soper; Joseph F Heyse; Marc Ferrer
Journal:  Bioinformatics       Date:  2011-08-16       Impact factor: 6.937

5.  Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy.

Authors:  Kristina J Allan; Douglas J Mahoney; Stephen D Baird; Charles A Lefebvre; David F Stojdl
Journal:  J Vis Exp       Date:  2018-04-03       Impact factor: 1.355

6.  Discovery of Druggable Host Factors Critical to Plasmodium Liver-Stage Infection.

Authors:  Rene Raphemot; Maria Toro-Moreno; Kuan-Yi Lu; Dora Posfai; Emily Rose Derbyshire
Journal:  Cell Chem Biol       Date:  2019-06-27       Impact factor: 8.116

7.  A whole-genome RNA interference screen for human cell factors affecting myxoma virus replication.

Authors:  Wondimagegnehu M Teferi; Kristopher Dodd; Rob Maranchuk; Nicole Favis; David H Evans
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

8.  Sex Differences in Nociceptor Translatomes Contribute to Divergent Prostaglandin Signaling in Male and Female Mice.

Authors:  Diana Tavares-Ferreira; Pradipta R Ray; Ishwarya Sankaranarayanan; Galo L Mejia; Andi Wangzhou; Stephanie Shiers; Ruta Uttarkar; Salim Megat; Paulino Barragan-Iglesias; Gregory Dussor; Armen N Akopian; Theodore J Price
Journal:  Biol Psychiatry       Date:  2020-10-05       Impact factor: 13.382

9.  GUItars: a GUI tool for analysis of high-throughput RNA interference screening data.

Authors:  Asli N Goktug; Su Sien Ong; Taosheng Chen
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

10.  Viability of developmental stages of Schistosoma mansoni quantified with xCELLigence worm real-time motility assay (xWORM).

Authors:  Gabriel Rinaldi; Alex Loukas; Paul J Brindley; Jeff T Irelan; Michael J Smout
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2015-08-06       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.